Literature DB >> 2452788

Human and murine antibodies to rye grass pollen allergen LolpIV share a common idiotope.

R Bose1, A K Ekramoddoullah, F T Kisil, A H Sehon.   

Abstract

The possibility that a murine monoclonal antibody (mAb 12) to Rye grass pollen allergen LolpIV and LolpIV-specific antibodies in the sera of grass allergic individuals share a common idiotope (Id) was investigated. It was first established that mAb 12 and human IgE antibodies recognized the same (or similar) epitope(s) on LolpIV; i.e. mAb 12 could inhibit, to the extent of 35-60%, the binding of 125I-LolpIV to the human IgE antibodies present in the sera of grass pollen-allergic individuals. Subsequently, a rabbit anti-Id antiserum was produced against mAb 12 and rendered Id-specific by appropriate immune absorptions, and its IgG antibody fraction was isolated (Rb-aId). The specificity of Rb-aId was demonstrated by the fact that the antibodies bound only to mAb 12 and not to any other murine monoclonal antibody tested. Observations that Rb-aId inhibited the binding of 125I-LolpIV to mAb 12 indicated that the Id determinants recognized on mAb 12 were located at or near the antibody-combining sites. The Rb-aId also bound specifically to affinity-purified human anti-LolpIV antibodies isolated from human sera, but not to affinity-purified human anti-tetanus toxoid antibodies. This indicated that the human anti-LolpIV antibodies share a cross-reactive Id. The binding of Rb-aId to human anti-LolpIV antibody could also be inhibited by mAb 12. Therefore, it was concluded that the murine and human antibodies to LolpIV share a cross-reactive idiotope.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2452788      PMCID: PMC1454784     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  12 in total

1.  Partial characterization of an antigenic site of high molecular weight basic antigen, a ryegrass pollen allergen, using a monoclonal antibody.

Authors:  A K Ekramoddoullah; F T Kisil; A H Sehon
Journal:  Mol Immunol       Date:  1986-02       Impact factor: 4.407

2.  Production and characterization of mouse monoclonal antibodies to allergenic epitopes on LolpI (Rye I).

Authors:  R Bose; E S Rector; J Fischer; R Taronno; G Delespesse
Journal:  Immunology       Date:  1986-10       Impact factor: 7.397

3.  General methods for the study of cells and serum during the immune response: the response to dinitrophenyl in mice.

Authors:  N R Klinman; R B Taylor
Journal:  Clin Exp Immunol       Date:  1969-04       Impact factor: 4.330

4.  Induction of anti-idiotypic antibodies by immunisation with syngeneic spleen cells educated with acetylcholine receptor.

Authors:  M Schwartz; D Novick; D Givol; S Fuchs
Journal:  Nature       Date:  1978-06-15       Impact factor: 49.962

5.  Towards a network theory of the immune system.

Authors:  N K Jerne
Journal:  Ann Immunol (Paris)       Date:  1974-01

6.  Chemical coupling of peptides and proteins to polysaccharides by means of cyanogen halides.

Authors:  R Axén; J Porath; S Ernback
Journal:  Nature       Date:  1967-06-24       Impact factor: 49.962

7.  Immunochemical characterization of a high molecular weight basic allergen (HMBA) of rye grass (Lolium perenne) pollen.

Authors:  A K Ekramoddoullah; F T Kisil; A H Sehon
Journal:  Mol Immunol       Date:  1983-04       Impact factor: 4.407

8.  Anti-idiotypes to anti-Lolp I (Rye) antibodies in allergic and non-allergic individuals. Influence of immunotherapy.

Authors:  R Bose; D G Marsh; G Delespesse
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

9.  Recognition of a site of a Kentucky bluegrass pollen allergen by antibodies in the sera of allergic and non-atopic humans and a murine monoclonal antibody.

Authors:  A K Ekramoddoullah; F T Kisil; R T Cook; A H Sehon
Journal:  J Immunol       Date:  1987-03-15       Impact factor: 5.422

10.  Demonstration of auto-anti-idiotypic antibody cross-reacting with public idiotypic determinants in the serum of rye-sensitive allergic patients.

Authors:  R Bose; D G Marsh; J Duchateau; A H Sehon; G Delespesse
Journal:  J Immunol       Date:  1984-11       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.